Cabot Growth Investor has been recommending the best stocks to buy since 1970. Since 2007, the Growth Investor advisory has earned more than double the return of the S&P 500.
Mike Cintolo guides growth-oriented investors to market-beating profits in our flagship advisory by combining expert stock selection with award-winning market timing. It’s a complete growth-oriented investment advisory for beginners through experts.
Cabot Growth Investor was founded in 1970, and has been consistently recognized as a top investment advisory by both Hulbert Financial Digest and Timer Digest. The advisory was named one of nine newsletters on Hulbert Financial Digest's Honor Roll in 2010 for outstanding performance in up and down markets and Timer Digest consistently ranks Cabot Growth Investor as one of the top long-term timers. The advisory provides specific portfolio allocation advice and a model portfolio, which may hold as many as 12 stocks. The performance shown is the gain since Mike Cintolo took over as chief analyst in January 2007, compared to the S&P 500, not including dividends, as of 4/24/15.
107% in LinkedIn
80% in Netflix
49% in Celgene
75% in Qihoo 360
Sign up now for a risk-free trial subscription to Cabot Growth Investor. Try Cabot Growth Investor for six months. If you don’t like it, you don’t pay.
FREE with your risk-free trial subscription: 10 Top IPOs for 10-Bagger Profits
What our Customers say about Cabot Growth Investor
Yours is the best info and newsletter that I read. It is short and to the point. Thank you. I'm an 80-year old investor that still works everyday and plays in the market. I love it. Up or down it's never dull.
E. Thomson, Shelby, Mississippi U.S.A.
Cabot newsletters are the only stock letters I can truly say I'm making money on. Thank you Cabot.
P. Wassiege, Quincy, Massachusetts
I have great respect for Cabot Market Letter, because it was, sequentially, bullish but anticipated the 2008 crash, the post-2008 rebound; and (reluctantly) the more recent stall.
Peter Brimelow, MarketWatch (5/31/12)
Are you ready to get started with your risk-free trial subscription?